4.6 Article

Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing

Journal

CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 53, Issue 12, Pages 1991-2002

Publisher

WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2015-0083

Keywords

antinuclear antibody; digital fluorescence; second generation ANA testing; standardization; systemic autoimmune rheumatic disease

Funding

  1. Federal Ministry of Economics and Technology Central Innovation Programme SME ZIM-KOOP [KF2379003AJ0, KF2379004AJ1]
  2. Federal Ministry of Education [InnoProfile 03IP611, InnoProfile-Transfer 03IPT611A, InnoProfile-Transfer 03IP611X]

Ask authors/readers for more resources

Background: For the serological diagnosis of systemic autoimmune rheumatic diseases, a two-tier approach starting with sensitive antinuclear antibody (ANA) detection by indirect immunofluorescence (IIF) on HEp-2 cells followed by characterization of positive findings with different immunoassays is recommended. To overcome drawbacks of this approach, we developed a novel technique allowing the combination of screening and simultaneous confirmatory testing. For the first time, this creates the basis for second generation ANA testing. Methods: ANA and autoantibodies (autoAbs) to double-stranded DNA (dsDNA), CENP-B, SS-A/Ro52, SS-A/Ro60, SS-B/La, RNP-Sm, Sm, and Scl-70 were determined by IIF and enzyme-linked immunosorbent assay (ELISA), respectively, and compared to simultaneous analysis thereof by second generation ANA analysis in patients with systemic lupus erythematosus (n = 174), systemic sclerosis (n = 103), Sjogren's syndrome (n = 46), rheumatoid arthritis (n = 36), mixed and undetermined connective tissue diseases (n = 13), myositis (n = 21), infectious disease (n = 21), autoimmune liver disease (n = 93), inflammatory bowel disease (n = 78), paraproteinemia (n = 11), and blood donors (n = 101). Results: There was very good agreement of second generation ANA testing with classical one by IIF and ELISA regarding testing for ANA and autoAbs to dsDNA, CENP-B, SS-B, RNP-Sm, Scl-70, SS-A/Ro52, and SS-A/Ro60 (Cohen's kappa>0.8). The agreement for anti-Sm autoAb was good (kappa=0.77). The differences of both approaches were not significant for autoAbs to SS-B/La, RNP-Sm, Scl-70, SS-A/Ro60, and SS-A/Ro52 (McNemar's test, p>0.05, respectively). Conclusions: Second generation ANA testing can replace the two-tier analysis by combining IIF screening with multiplex confirmative testing. This addresses shortcomings of classical ANA analysis like false-negative ANA findings and lack of laboratory efficiency and standardization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available